article thumbnail

AbbVie announces its new CEO

European Pharmaceutical Review

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

article thumbnail

Exploring the societal impact of digital health research and innovation

Clarivate

From just 39 publications in 2013, the number soared nearly 70-fold to 2,641 in 2022, totaling 7,944 over the decade. From 93 papers in 2013, the publication pool expanded to 7,662 papers by 2022. Data source: Web of Science, Clarivate).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lung cancer deaths decline but.

World of DTC Marketing

But it’s still the leading cause of cancer deaths. Moreover, localized lung cance r diagnoses rose to 28% in 2018 from 20% in 2013— the year that the U.S. Although lung cancer’s mortality rate has fallen, the disease is still the leading cause of cancer deaths. American Cancer Society’s ACS ).

Medicine 271
article thumbnail

Neglected tropical diseases: non-profits lead the way as private sectors lags

Pharmaceutical Technology

Four countries managed to get rid of river blindness after adopting elimination strategies, with the first being Colombia in 2013. The post Neglected tropical diseases: non-profits lead the way as private sectors lags appeared first on Pharmaceutical Technology. DNDi has four treatments in the pipeline that target the adult worm.

Leads 64
article thumbnail

HCP’s use of social media: the good and the not so good

World of DTC Marketing

HCPs are also connecting more than ever: one study showed that HCP posts about healthcare increased from 10% in 2013 to 50% in 2019. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug. 33 Even now, nearly 70% of all HCPs are digital natives.

Media 294
article thumbnail

Pharma R&D productivity dips, but efficiency gains give hope

Clarivate

Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.

Pharma 52
article thumbnail

AbbVie Cork facility €60 million expansion

European Pharmaceutical Review

Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. to lead R&D organization and drive continued pipeline advancement… The post AbbVie Cork facility €60 million expansion appeared first on European Pharmaceutical Review. AbbVie announces Michael Severino, M.D.